Fingerprint
Dive into the research topics of 'The orally active melanocortin-4 receptor antagonist BL-6020/979: A promising candidate for the treatment of cancer cachexia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The orally active melanocortin-4 receptor antagonist BL-6020/979: A promising candidate for the treatment of cancer cachexia
R. Dallmann, P. Weyermann, C. Anklin, M. Boroff, K. Bray-French, B. Cardel, I. Courdier-Fruh, H. Deppe, J. Dubach-Powell, M. Erb, R. H. Haefeli, M. Henneböhle, H. Herzner, M. Hufschmid, D. L. Marks, S. Nordhoff, M. Papp, C. Rummey, G. Santos, F. Schärer
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations